Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (33 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 31 Jan 2024 – 20 Aug 2026, limited by DSP Multicap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | DSP Multicap Fund | Nifty 500 |
|---|---|---|
| 31 Jan 2024 | ₹100.00 | ₹100.00 |
| 18 Apr 2024 | ₹101.94 | ₹102.64 |
| 04 Jul 2024 | ₹120.21 | ₹115.72 |
| 20 Sep 2024 | ₹127.26 | ₹122.18 |
| 07 Dec 2024 | ₹123.70 | ₹117.73 |
| 22 Feb 2025 | ₹105.70 | ₹104.49 |
| 11 May 2025 | ₹109.24 | ₹109.46 |
| 28 Jul 2025 | ₹120.47 | ₹115.38 |
| 13 Oct 2025 | ₹121.38 | ₹117.64 |
| 30 Dec 2025 | ₹119.62 | ₹119.53 |
| 18 Mar 2026 | ₹110.45 | ₹110.68 |
| 03 Jun 2026 | ₹116.68 | ₹113.38 |
| 20 Aug 2026 | ₹124.82 | ₹118.74 |
| Metric | DSP · Regular NAV ₹12.50 Very High risk ★★☆☆☆ 1Y | Category median Multi Cap Fund · 33 funds |
|---|---|---|
| +2.14% | +8.06% | |
| — | +15.20% | |
| — | +14.26% | |
| — | +14.26% | |
| +9.08% | +14.72% | |
| +5.97% | — | |
| — | +16.83% | |
| — | +15.79% | |
| — | +14.87% | |
| Risk | ||
| 14.79% | 14.84% | |
| -0.29 | 0.56 | |
| -0.40 | 0.76 | |
| -21.71% | -20.32% | |
| Nifty 500 | — | |
| +2.16% | +2.81% | |
| 1.06 | 1.01 | |
| 110.3% | 110.1% | |
| 102.1% | 95.9% | |
| 2.09% | 2.21% | |
| ₹2,765Cr | ₹3,513Cr | |
| 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 22% | 56% | |
| Chirag Dagli · 2.6y | — | |
| 31 Jan 2024 | — | |
| 59 | — | |
| 30.5% | — | |
| 10.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.